NASDAQ:PAHC - Phibro Animal Health Stock Price, News & Analysis

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Phibro Animal Health declared a quarterly dividend on Monday, July 29th. Investors of record on Wednesday, September 4th will be paid a dividend of $0.12 per share on Wednesday, September 25th. This represents a $0.48 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date is Tuesday, September 3rd. View Phibro Animal Health's Dividend History.

Phibro Animal Health Corp (NASDAQ:PAHC) posted its earnings results on Tuesday, August, 27th. The company reported $0.33 EPS for the quarter, missing the consensus estimate of $0.34 by $0.01. The firm earned $203.90 million during the quarter, compared to analysts' expectations of $206 million. Phibro Animal Health had a return on equity of 29.99% and a net margin of 6.59%. The company's revenue was down 3.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.46 earnings per share. View Phibro Animal Health's Earnings History.

Phibro Animal Health is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Phibro Animal Health.

Phibro Animal Health updated its FY20 earnings guidance on Tuesday, August, 27th. The company provided earnings per share guidance of $1.08 -1.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.66. The company issued revenue guidance of $833 -863 million, compared to the consensus revenue estimate of $857.96 million.

5 equities research analysts have issued twelve-month target prices for Phibro Animal Health's stock. Their predictions range from $18.00 to $42.00. On average, they anticipate Phibro Animal Health's stock price to reach $26.60 in the next twelve months. This suggests a possible upside of 21.9% from the stock's current price. View Analyst Price Targets for Phibro Animal Health.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Phibro Animal Health.

News articles about PAHC stock have been trending negative this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Phibro Animal Health earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Phibro Animal Health.

Phibro Animal Health saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 839,000 shares, an increase of 5.3% from the July 31st total of 796,900 shares. Based on an average daily trading volume, of 153,700 shares, the short-interest ratio is currently 5.5 days. Approximately 4.2% of the shares of the stock are short sold. View Phibro Animal Health's Current Options Chain.

Some companies that are related to Phibro Animal Health include FibroGen (FGEN), Nektar Therapeutics (NKTR), Evotec (EVTCY), Alkermes (ALKS), Mirati Therapeutics (MRTX), Taro Pharmaceutical Industries (TARO), Global Blood Therapeutics (GBT), BridgeBio Pharma (BBIO), HUTCHISON CHINA/S (HCM), Arrowhead Pharmaceuticals (ARWR), Emergent Biosolutions (EBS), Genmab A/S (GMAB), Reata Pharmaceuticals (RETA), Arena Pharmaceuticals (ARNA) and Ultragenyx Pharmaceutical (RARE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Zoetis (ZTS), Booking (BKNG), Ophthotech (OPHT) and RetailMeNot (SALE).

Phibro Animal Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.04%), Vanguard Group Inc. (5.58%), Fiduciary Management Inc. WI (2.65%), Janus Henderson Group PLC (2.37%), Janus Henderson Group PLC (2.37%) and Renaissance Technologies LLC (1.87%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran, Jack Bendheim and Larry Lee Miller. View Institutional Ownership Trends for Phibro Animal Health.

PAHC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, D. E. Shaw & Co. Inc., Prudential Financial Inc., Wells Fargo & Company MN, Citadel Advisors LLC, AQR Capital Management LLC and Invesco Ltd.. Company insiders that have sold Phibro Animal Health company stock in the last year include Daniel M Bendheim and Dean J Warras. View Insider Buying and Selling for Phibro Animal Health.

PAHC stock was bought by a variety of institutional investors in the last quarter, including Fiduciary Management Inc. WI, Janus Henderson Group PLC, Janus Henderson Group PLC, Nuveen Asset Management LLC, Chartwell Investment Partners LLC, Marshall Wace LLP, Vanguard Group Inc. and Tocqueville Asset Management L.P.. View Insider Buying and Selling for Phibro Animal Health.

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PAHC stock can currently be purchased for approximately $21.82.

Phibro Animal Health has a market capitalization of $882.62 million and generates $828 million in revenue each year. The company earns $54.71 million in net income (profit) each year or $1.53 on an earnings per share basis. Phibro Animal Health employs 1,600 workers across the globe.View Additional Information About Phibro Animal Health.

The official website for Phibro Animal Health is http://www.pahc.com/.

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]